[
    [
        {
            "time": "2023-01-05",
            "original_text": "Q4 Earnings Outlook For AbbVie",
            "features": {
                "keywords": [
                    "Q4",
                    "Earnings",
                    "Outlook",
                    "AbbVie"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Q4 Earnings Outlook For AbbVie",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-01-05",
            "original_text": "Form 8.3 - ABBVIE INC - Amendment",
            "features": {
                "keywords": [
                    "Form",
                    "8.3",
                    "ABBVIE",
                    "INC",
                    "Amendment"
                ],
                "sentiment_score": 0.0,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "Form 8.3 - ABBVIE INC - Amendment",
                "Correlation": 10,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 6,
                "Headline_Structure": 4,
                "Source_Recency": 9
            }
        },
        {
            "time": "2023-01-05",
            "original_text": "AbbVie Climbs Pre-Earnings on Analyst Nod, Coronavirus Drug Demand",
            "features": {
                "keywords": [
                    "AbbVie",
                    "Climbs",
                    "Pre-Earnings",
                    "Analyst",
                    "Nod",
                    "Coronavirus",
                    "Drug",
                    "Demand"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "AbbVie Climbs Pre-Earnings on Analyst Nod, Coronavirus Drug Demand",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 8,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "2023-01-05",
            "original_text": "Allergan (AGN) to Report Q4 Earnings: What's in the Cards?",
            "features": {
                "keywords": [
                    "Allergan",
                    "AGN",
                    "Q4",
                    "Earnings"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Allergan (AGN) to Report Q4 Earnings: What's in the Cards?",
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 6,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2023-01-05",
            "original_text": "Form 8.3 - ABBVIE INC - AMENDMENT",
            "features": {
                "keywords": [
                    "Form",
                    "8.3",
                    "ABBVIE",
                    "INC",
                    "AMENDMENT"
                ],
                "sentiment_score": 0.0,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "Form 8.3 - ABBVIE INC - AMENDMENT",
                "Correlation": 10,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 6,
                "Headline_Structure": 4,
                "Source_Recency": 9
            }
        }
    ]
]